MelvinAlbertChurchillJr.MDFACR

Rheumatology • Lincoln, NE

Osteoporosis & Bone Metabolism

Founder Arthritis Center of Nebraska ;Director Physician Research Collaboration

Join to view full profile

Dr. Churchill is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Churchill's full profile

Already have an account?

Office
3901 Pine Lake Rd
Suite 120
Lincoln, NE 68516
Phone+1 402-420-1212

Fax+1 402-328-0961
Is this information wrong?

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Rheumatology, 1977 - 1978
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1973 - 1977
University of Nebraska Medical Center College of MedicineInternship, Internal Medicine, 1972 - 1973
University of Nebraska College of MedicineClass of 1972

Certifications & Licensure

NE State Medical License 1972 - 2024
MN State Medical License 1973 - 1979
IA State Medical License 1975 - 1979
WI State Medical License 1977 - 1978
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2011-2013
Fellow (FACR) American College of Rheumatology

Clinical Trials

Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2012 Jun 01
Completed
Phase 2
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus Start of enrollment: 2014 Jan 01
Terminated
Phase 3
A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis Start of enrollment: 2016 May 02
Completed
Phase 3
A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis Start of enrollment: 2016 Aug 02
Completed
Phase 3
A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis Start of enrollment: 2017 May 09
Completed
Phase 3
Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2) Start of enrollment: 2020 Jul 01
Active, not recruiting
Phase 3
Roles: Contact
Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1) Start of enrollment: 2020 Jul 01
Recruiting
Phase 3
Roles: Contact
Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis Start of enrollment: 2022 Jun 30
Recruiting
Phase 3
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

7 citations
Secukinumab in United States Biologic-Naïve Patients With Psoriatic Arthritis: Results From the Randomized, Placebo-Controlled CHOICE Study.
Tien Nguyen, Melvin Churchill, Robert Levin, Guillermo Valenzuela, Joseph F Merola, Alexis Ogdie, Ana-Maria Orbai, Jose U Scher, Arthur Kavanaugh, Farid Kianifard, Cha...> ;The Journal of Rheumatology. 2022 Aug 1
105 citations
Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial
Atul Deodhar, Désirée van der Heijde, Lianne S. Gensler, Tae-Hwan Kim, Walter P. Maksymowych, Mikkel Østergaard, Denis Poddubnyy, Helena Marzo-Ortega, Louis Bessette, ...> ;Lancet. 2020 Jan 4
179 citations
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biol...
Désirée van der Heijde, James Cheng-Chung Wei, Maxime Dougados, Philip J. Mease, Atul Deodhar, Walter P. Maksymowych, Filip Van den Bosch, Joachim Sieper, Tetsuya Tomi...> ;Lancet. 2018 Dec 8
268 citations
Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week rand...
Peter Nash, Bruce Kirkham, Masato Okada, Proton Rahman, B. Combe, Gerd Burmester, David H. Adams, Lisa Kerr, Chin Lee, Catherine L Shuler, Mark C. Genovese, Khalid Ahm...> ;Lancet. 2017 Jun 10
30 citations
Efficacy and Safety of Subcutaneous Golimumab in Methotrexate-Naive Patients With Rheumatoid Arthritis: Five-Year Results of a Randomized Clinical Trial.
Paul Emery, Roy Fleischmann, Ingrid Strusberg, Patrick Durez, Peter Nash, Eric Amante, Melvin Churchill, Won Park, Bernardo A. Pons-Estel, Chenglong Han, T. Gathany, S...> ;Arthritis Care & Research. 2016 Jun 1
21 citations
A Randomized Trial Comparing Disease Activity Measures for the Assessment and Prediction of Response in Rheumatoid Arthritis Patients Initiating Certolizumab Pegol.
Jeffrey R. Curtis, Melvin Churchill, Alan Kivitz, Ahmed Samad, Laura Gauer, L. Gervitz, W. Koetse, Jeffrey M. Melin, Yusuf Yazici> ;Arthritis & Rheumatology. 2015 Dec 1
28 citations
Golimumab, a human anti–tumor necrosis factor monoclonal antibody, injected subcutaneously every 4 weeks in patients with active rheumatoid arthritis who had never tak...
Paul Emery, Roy Fleischmann, Mittie K. Doyle, Ingrid Strusberg, Patrick Durez, Peter Nash, Eric Amante, Melvin Churchill, Won Park, Bernardo A. Pons-Estel, W. Xu, Step...> ;Arthritis Care & Research. 2013 Nov 1
320 citations
Golimumab, a human anti-tumor necrosis factor alpha monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid...
Paul Emery, Roy Fleischmann, Larry W. Moreland, Elizabeth C. Hsia, Ingrid Strusberg, Patrick Durez, Peter Nash, Eric Amante, Melvin Churchill, Won Park, Bernardo A. Po...> ;Arthritis and Rheumatism. 2009 Aug 1
200 citations
Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: Results of a two...
James R. O'Dell, Robert D Leff, Gail Paulsen, Claire E. Haire, Jack A. Mallek, P. James Eckhoff, Ana Fernández, Kent Blakely, Steven Wees, Julie A. Stoner, Stephen Had...> ;Arthritis and Rheumatism. 2002 May 1
70 citations
Treatment of early seropositive rheumatoid arthritis with minocycline: four-year followup of a double-blind, placebo-controlled trial.
James R. O'Dell, Gail Paulsen, Claire E. Haire, Kent Blakely, William E. Palmer, Steven Wees, P. James Eckhoff, Lynell Warren Klassen, Melvin Churchill, Deborah K. Dou...> ;Arthritis and Rheumatism. 1999 Aug 1
118 citations
TREATMENT OF EARLY RHEUMATOID ARTHRITIS WITH MINOCYCLINE OR PLACEBO Results of a Randomized, Double-Blind, Placebo-Controlled Trial
James R. O'Dell, Claire E. Haire, William E. Palmer, Walter Drymalski, Steven Wees, Kent Blakely, Melvin Churchill, P. James Eckhoff, Arthur L. Weaver, Deborah K. Doud...> ;Arthritis and Rheumatism. 1997 May 1
Join now to see all

Professional Memberships

American Medical Association - AMA
Member
American College of Rheumatology - ACR
Fellow
International Society of Clinical Densitometry
Member

Hospital Affiliations

Bryan Medical CenterLincoln, Nebraska
CHI Health St ElizabethLincoln, Nebraska